Screener
Amgen AMGN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Amgen in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Amgen’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 7:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000318154-26-000057
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $2,935 | $2,367 |
| Accrued liabilities | 16,583 | 18,523 |
| Current portion of long-term debt | 5,437 | 4,599 |
| Total current liabilities | 24,955 | 25,489 |
| Long-term debt | 51,886 | 50,005 |
| Long-term deferred tax liabilities | 1,344 | 1,366 |
| Long-term tax liabilities | 2,764 | 2,690 |
| Other noncurrent liabilities | 2,365 | 2,378 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Amgen's total current liabilities?
- Amgen (AMGN) reported total current liabilities of $24.96B in Q1 2026.
- How has Amgen's total current liabilities changed year-over-year?
- Amgen's total current liabilities increased by 8.5% year-over-year, from $23.01B to $24.96B.
- What is the long-term trend for Amgen's total current liabilities?
- Over 5 years (2020 to 2025), Amgen's total current liabilities has grown at a 16.9% compound annual growth rate (CAGR), from $11.65B to $25.49B.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Amgen's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude